Adrianna Hyams, NP
Nurse Practitioner · Newburgh, INNPI 1386179695
Payments from drug & device makers
Across 391 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$642
- Bristol Myers Squibb$600
- Takeda Pharmaceuticals U.S.A., Inc.$279
- Teva Pharmaceuticals USA, Inc.$263
- Gilead$240
- plus $2K from 34 others
What the payments were for
- Food & beverage$5,94897%
- Education$1603%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 132 | $1,586 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 41 | $642 |
| Bristol Myers Squibb | 46 | $600 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $279 |
| Teva Pharmaceuticals USA, Inc. | 11 | $263 |
| Gilead | 18 | $240 |
| Johnson & Johnson | 11 | $207 |
| Eisai Inc. | 6 | $190 |
| Pfizer | 14 | $180 |
| SK Life Science, Inc. | 8 | $178 |
| Sanofi | 8 | $149 |
| Intercept Pharmaceuticals, Inc. | 9 | $143 |
| Regeneron Healthcare Solutions, Inc. | 5 | $136 |
| Amgen | 8 | $135 |
| Daiichi Sankyo Inc. | 6 | $133 |
| Catalyst Pharmaceuticals, Inc. | 4 | $98 |
| Lundbeck LLC | 5 | $92 |
| Jazz Pharmaceuticals Inc. | 3 | $84 |
| TG Therapeutics, Inc. | 3 | $81 |
| Neurelis, Inc. | 4 | $76 |
| Ironwood Pharmaceuticals, Inc | 3 | $71 |
| UCB, Inc. | 3 | $63 |
| Novartis | 3 | $58 |
| Braintree Laboratories, Inc. | 4 | $57 |
| Genentech USA, Inc. | 2 | $43 |
| Boston Scientific | 2 | $41 |
| Neurocrine Biosciences, Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Organon | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| CSL Behring | 1 | $20 |
| Merck | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Cala Health, Inc. | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $14 |
| QOL Medical, LLC | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$6,108 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 12 | $230 |
| Fluticasone Propionate | 15 | $141 |
| Doxycycline Monohydrate | 18 | $135 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $120 |
| Cephalexin | 13 | $61 |
| Amoxicillin | 19 | $35 |
| Prednisone | 15 | $26 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Newburgh
- Kimberly BurkNewburgh$27K
- Shannon KratzerNewburgh$12K
- Elise SchuttNewburgh$10K
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.